洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2600125751】To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes

基本信息
登记号

ChiCTR2600125751

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-05-30

临床申请受理号

/

靶点

/

适应症

Autism Spectrum Disorder

试验通俗题目

To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes

试验专业题目

To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

This study aims to investigate the association of mutations in MAU2 and ZFHX3, as well as other structural variants, with autism spectrum disorder (ASD) in individuals from Hong Kong. To explore distinct clinical features associated with MAU2 and ZFHX3, and other potential SVs mutations in ASD.

试验分类
请登录查看
试验类型

横断面

试验分期

其它

随机化

None

盲法

None

试验项目经费来源

Alice Ho Miu Ling Nethersole Charity Foundation

试验范围

/

目标入组人数

400

实际入组人数

/

第一例入组时间

2026-04-08

试验终止时间

2029-09-30

是否属于一致性

/

入选标准

1 Reported by parents to be autistic or ASD with confirmation from health care professional workers. The probands must have received a valid and reliable assessment and must meet cutoffs for autism spectrum or autism. (E.g. The newest ADOS algorithms to be used for Modules 1 - 3 and the original cutoff algorithms to be used for Module 4; or a clinical “Best Estimate Diagnosis,” of Autistic Disorder, Asperger’s Disorder, or PDD-NOS, according to the ADOS or DSM-IV-TR or DSM-5 or DSM-5-TR). 2 Age: The proband that age between 1 and 18 years old, their parents and any first-degree relatives (autistic or not) will also be recruited in anticipation that these samples will be valuable resources for further understanding of the genetic factors that might contribute to the phenotype. 3 Being ethnic Chinese 1 Reported by parents to be autistic or ASD with confirmation from health care professional workers. The probands must have received a valid and reliable assessment and must meet cutoffs for autism spectrum or autism. (E.g. The newest ADOS algorithms to be used for Modules 1 - 3 and the original cutoff algorithms to be used for Module 4; or a clinical “Best Estimate Diagnosis,” of Autistic Disorder, Asperger’s Disorder, or PDD-NOS, according to the ADOS or DSM-IV-TR or DSM-5 or DSM-5-TR).2 Age: The proband that age between 1 and 18 years old, their parents and any first-degree relatives (autistic or not) will also be recruited in anticipation that these samples will be valuable resources for further understanding of the genetic factors that might contribute to the phenotype. 3 Being ethnic Chinese;

排除标准

1 With significant injury, abnormality, or disease having effects upon the brain, extensive complications during birth or pregnancy (careful screening will be carried out for those who stayed in the hospital for more than 3 days after birth). 2 With significant nutritional and psychological deprivation*. 3 Other known genetic disorders: e.g. Down's syndrome, or Fragile X syndrome. 4 Those diagnosed with a known genetic disorder, and those with a psychiatric disorder require medication.;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Nethersole School of Nursing, The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Nethersole School of Nursing, The Chinese University of Hong Kong的其他临床试验

The Nethersole School of Nursing, The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用